Accurate non-ceruloplasmin bound copper: a new biomarker for the assessment and monitoring of Wilson disease patients using HPLC coupled to ICP-MS/MS.

MLA

Harrington, Chris F., et al. “Accurate Non-Ceruloplasmin Bound Copper: A New Biomarker for the Assessment and Monitoring of Wilson Disease Patients Using HPLC Coupled to ICP-MS/MS.” Clinical Chemistry and Laboratory Medicine, July 2024. EBSCOhost, https://doi.org/10.1515/cclm-2024-0213.

APA

Harrington, C. F., Carpenter, G., Coverdale, J. P. C., Douglas, L., Mills, C., Willis, K., & Schilsky, M. L. (2024). Accurate non-ceruloplasmin bound copper: a new biomarker for the assessment and monitoring of Wilson disease patients using HPLC coupled to ICP-MS/MS. Clinical Chemistry and Laboratory Medicine. https://doi.org/10.1515/cclm-2024-0213

Chicago

Harrington, Chris F, Geoff Carpenter, James P C Coverdale, Leisa Douglas, Craig Mills, Karl Willis, and Michael L Schilsky. 2024. “Accurate Non-Ceruloplasmin Bound Copper: A New Biomarker for the Assessment and Monitoring of Wilson Disease Patients Using HPLC Coupled to ICP-MS/MS.” Clinical Chemistry and Laboratory Medicine, July. doi:10.1515/cclm-2024-0213.